SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-027408
Filing Date
2019-05-07
Accepted
2019-05-07 11:30:44
Documents
9
Period of Report
2019-05-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a19-9458_18k.htm 8-K 30984
2 EX-99.1 a19-9458_1ex99d1.htm EX-99.1 9554
3 EX-99.2 a19-9458_1ex99d2.htm EX-99.2 9538
4 EX-99.3 a19-9458_1ex99d3.htm EX-99.3 8044
5 EX-99.4 a19-9458_1ex99d4.htm EX-99.4 7996
6 GRAPHIC g94581mmi001.gif GRAPHIC 378775
7 GRAPHIC g94581msi001.gif GRAPHIC 301995
8 GRAPHIC g94581mqi001.gif GRAPHIC 313295
9 GRAPHIC g94581moi001.gif GRAPHIC 293452
  Complete submission text file 0001104659-19-027408.txt   1839951
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38080 | Film No.: 19801922
SIC: 2834 Pharmaceutical Preparations